Melody Transcatheter Valve Shows Promising Results in Study on Patients with Congenital Heart Disease

Clinical trial results published in this week’s Journal of the American College of Cardiology (JACC) describe six-month outcomes for patients using the Melody Transcatheter Pulmonary Valve from Medtronic, Inc. The valve is implanted through a catheter procedure instead of open-heart surgery in patients with congenital heart disease affecting the function of their pulmonary valve.